ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 20

Enthesitis-Related Arthritis: Non-Peripheral Pattern is Associated with an Expansion of Peripheral Th17 Populations

Maria M. Katsicas1, Carolina Carrara2, Andrea Bernasconi3, Jorge Rossi4 and Ricardo Russo5, 1Service of Immunology & Rheumatology., Hospital de Pediatría Prof Dr JP Garrahan, Buenos Aires, Argentina, 2Immunology& Rheumatology, Hospital de Pediatría Prof Dr JP Garrahan, Buenos Aires, Argentina, 3Immunology &Rheumatology, Hospital de Pediatría Prof Dr JP Garrahan, Buenos Aires, Argentina, 4Immunology & Rheumatology, Hospital de Pediatría Prof Dr JP Garrahan, Buenos Aires, Argentina, 5Immnology & Rheumatology, Hospital de Pediatría Prof Dr JP Garrahan, Buenos Aires, Argentina

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: T cells and juvenile spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Genetics and Pathogenesis Poster Breakout I

Session Type: Abstract Submissions

Session Time: 4:45PM-5:15PM

Background/Purpose:

Enthesitis-related arthritis (ERA) is a category of juvenile idiopathic arthritis. Different proinflammatory cytokines linked to the Th1 and Th17 T- cell subsets have been implicated in its pathogenesis. Limited data are currently available about the relationship between disease activity and the clinical pattern and the percentage of Th1/ Th17 T- cell subsets. Our objectives were  to analyze Th1 and Th17 cell subsets in patients with ERA and to compare with age-matched healthy controls. To assess the association between disease activity and disease clinical pattern with Th1and Th17 cells subsets

Methods:  Patients with ERA (according to ILAR criteria) were included in a cross sectional study. Disease activity measures were collected in random visits: active joint count (AJ), pain score (0-10), active enthesitis (AE), sacroiliac pain (SIP) , lumbar pain (LP),lumbar limitation (LL) by Schöber´s test, wellbeing according to the patient using a visual analogue scale (VASp, 0-10), disease activity according to the physician (VASphy), JADAS-10, JSpADA, and ESR were evaluated. Patients were classified based on the articular pattern (peripheral and non-peripheral) depending on the presence or absence of AJ and/or AE. Functional capacity by CHAQ. Presence of radiologic sacroiliitis (MRI/X-rays) and treatment were recorded. Th-17 and Th-1 cells were quantified by flow cytometry in PBMCs stimulated with PMA/IO. Age-matched healthy children without disease or medication were recruited as normal control. Statical analysis:Mann-Whitney U test and correlation tests.

Results:  29 patients (90 % M) fulfilled inclusion criteria. HLA-B27 was positive in 13 (45%). Median age was 12 years and disease duration was 2.1 years at observation. Activity and functional measures were (medians): AJ 1, pain 0.25, VASp 0.5, VASphy 1, JADAS-10 7, JSpADA 1.75, ESR 15 mm/h; CHAQ ≥ 0.5 occurred in 8 patients (27%). AE was present in 1 (3%), SIP in 7 (24 %), LP in 6 (21%), and LL in 12 (41%) children. Nineteen (65%) patients showed JADAS >1 and 21 (76%) JSpADA>0. Radiologic sacroilitis was recorded in 21(72%) children. Fourteen (48%) patients were treated with TNFi. Th1cell percentage in ERA was 8.5±3.4% (range, 4-17.4) while healthy controls was 5.8±3.8% (range, 1.2-14.2), p=0.023. Th17cell% in ERA was 0.90±0.44(range, 0.39-2.34%) while controls was 0,55±0.38 (range, 0,17-1,61%); p=0.004. There was no difference between T-cells and active/inactive disease according scores. Eighteen (62%) children showed peripheral pattern, while 11(38%) exhibited non-peripheral. Peripheral and non-peripheral groups showed Th17% cells 0.90(0.39-1.74) vs 1.14(0.64-2.44) respectively(p=0.018).Significant correlations with Th1: AJ (r=0.45 p=0.004) and with Th17: LP (r=0.83 p=0,0001), LL (r=0.47 p=0.03).

Conclusion:

Th1 and Th17 cells subsets were significantly higher in ERA compared with healthy controls. However, T-cells showed no significant difference between patients with active versus inactive disease.Interestingly, non-peripheral pattern showed higher Th17% cells with respect to patients with peripheral disease pattern. ERA with axial arthritis may benefit most from Th-17 blocking strategies.


Disclosure: M. M. Katsicas, None; C. Carrara, None; A. Bernasconi, None; J. Rossi, None; R. Russo, None.

To cite this abstract in AMA style:

Katsicas MM, Carrara C, Bernasconi A, Rossi J, Russo R. Enthesitis-Related Arthritis: Non-Peripheral Pattern is Associated with an Expansion of Peripheral Th17 Populations [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/enthesitis-related-arthritis-non-peripheral-pattern-is-associated-with-an-expansion-of-peripheral-th17-populations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enthesitis-related-arthritis-non-peripheral-pattern-is-associated-with-an-expansion-of-peripheral-th17-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology